Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis
NCT02792946 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 244
Last updated 2017-06-16
Summary
Compare the efficacy and safety of surfolase CR tablet with surfolate capsule in patients with acute bronchitis
Conditions
- Acute Bronchitis
Interventions
- DRUG
-
Acebrophylline
Sponsors & Collaborators
-
Hyundai Pharmaceutical Co., LTD.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
More Related Trials
-
Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
NCT03489837 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting
NCT06142994 ·Status: COMPLETED ·Phase: NA
-
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects
NCT06828120 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT04643587 ·Status: COMPLETED ·Phase: PHASE1
-
Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD
NCT03623282 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis
NCT04308681 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
NCT03334916 ·Status: COMPLETED ·Phase: PHASE4
-
N-Acetylcysteine for Patients With COPD and ChronicBronchitis
NCT01599884 ·Status: UNKNOWN ·Phase: NA
-
The Safety and Effectiveness of Taneasy and Actein in COPD Patients
NCT06688292 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
NCT02058407 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study
NCT01645800 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis
NCT01818544 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom
NCT01715493 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
NCT01597635 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
NCT07061925 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
NCT01416480 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study of RSS0343 in Healthy Subjects
NCT07289464 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis
NCT00769119 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.
NCT05258877 ·Status: COMPLETED
-
The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
NCT03502902 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis
NCT02714283 ·Status: COMPLETED
-
A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects
NCT04720443 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02249338 ·Status: COMPLETED ·Phase: PHASE2